EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model

Manal Moustafa Mahmoud iD, Laila Ahmed Rashed iD, Somia Abdulatif Soliman iD, Safaa Mostafa Sayed, Omneya Kamel, Samaa Samir Kamar iD, Rania El Sayed Hussien iD

Physiological Reports · 2023

DOI: 10.14814/phy2.15858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Manal Moustafa Mahmoud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Metformin, Polycystic Ovary Syndrome, Sodium-Glucose Transporter 2 Inhibitors, Insulin Resistance. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a common endocrine, reproductive, and metabolic disorder affecting females. The management of PCOS is challenging and current interventions are not enough to deal with all consequences of this syndrome. We explored the beneficial effect of combined sodium glucose co transporter‐2 inhibitor (SGLT‐2i); (empagliflozin) and metformin on hormonal and metabolic parameters in an animal model of PCOS and insulin resistance (IR). Forty adult female Wistar rats divided into five groups: control, PCOS‐IR, PCOS‐IR treated with metformin, PCOS‐IR treated with empagliflozin, and PCOS‐IR treated with combined metformin and empagliflozin. Single modality treatment with metformin or empagliflozin yielded significant improvement in body mass index, insulin resistance, lipid profile, sex hormones, inflammatory markers, and ovarian cystic follicles. Combined metformin with empagliflozin expressed further significant improvement in sex hormones, inflammatory markers with disappearance of ovarian cystic follicles. The superior significant improvement with combined treatment over the single modality was in line with significant improvement in the ovarian AMPKα‐SIRT1 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminPolycystic Ovary SyndromeSodium-Glucose Transporter 2 InhibitorsInsulin ResistanceHumansRatsFemaleAnimalsRats, WistarInsulinGonadal Steroid HormonesBenzhydryl CompoundsGlucosides

Stichwörter der Autor:innen

AMPKα-SIRT1PCOSempagliflozininsulin resistancemetformin

Substanzen

MetforminSodium-Glucose Transporter 2 InhibitorsInsulinGonadal Steroid HormonesempagliflozinBenzhydryl CompoundsGlucosides

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Biochemistry Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Physiology, School of Medicine, New Giza University, Cairo, Egypt.
  • Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Histology, Armed Forces College of Medicine, Cairo, Egypt.

ORCID-Profile: Manal Moustafa Mahmoud, Laila Ahmed Rashed, Somia Abdulatif Soliman, Samaa Samir Kamar, Rania El Sayed Hussien

Zitieren

APA

Mahmoud, M. M., Rashed, L. A., Soliman, S. A., Sayed, S. M., Kamel, O., Kamar, S. S., & Hussien, R. E. S. (2023). SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. https://doi.org/10.14814/phy2.15858

Vancouver

Mahmoud MM, Rashed LA, Soliman SA, Sayed SM, Kamel O, Kamar SS, et al. SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. 2023. doi:10.14814/phy2.15858

BibTeX
@article{Mahmoud2023,
  author = {Mahmoud, Manal Moustafa and Rashed, Laila Ahmed and Soliman, Somia Abdulatif and Sayed, Safaa Mostafa and Kamel, Omneya and Kamar, Samaa Samir and Hussien, Rania El Sayed},
  title = {SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15858}
}
Kostenlos starten →